Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Thyroid CancerPapillary Microcarcinoma
Interventions
BEHAVIORAL

Focus groups

"The focus groups will cover the following issues~* Perceptions of thyroid cancer and disease status~* Sources of information used in papillary microcarcinoma treatment decision-making~* Treatment decision-making processes and influential factors~* Perceived barriers to active surveillance to treat papillary microcarcinoma (for the immediate surgery sub-sample)~* Perceived facilitators to active surveillance to treat papillary microcarcinoma (for the non-immediate surgery sub-sample)~* Views about how to improve acceptability of active surveillance as a disease management option"

BEHAVIORAL

Focus groups

"The focus groups will cover the following issues:~* Perceptions of thyroid cancer and disease status~* Sources of information used in papillary microcarcinoma treatment decision-making~* Treatment decision-making processes and influential factors~* Perceived barriers to active surveillance to treat papillary microcarcinoma (for the immediate surgery sub-sample)~* Perceived facilitators to active surveillance to treat papillary microcarcinoma (for the non-immediate surgery sub-sample)~* Views about how to improve acceptability of active surveillance as a disease management option"

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01392222 - Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others | Biotech Hunter | Biotech Hunter